MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
NTLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Intellia Therapeutics (NTLA) Ownership - Who owns Intellia Therapeutics?

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
377
Web
https://www.intelliatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.13B
P/E Ratio
N/A
Total Cash
375.99M
Projected Growth
N/A
Total Debt
80.49M
Revenue
66.09M
Risk (Beta)
2.44
Dividend Yield
N/A
Total Cash/Share
2.69
Total Debt/Equity
N/A
Revenue/Share
0.55 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NTLA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for NTLA
A.I. Advisor
published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
377
Web
https://www.intelliatx.com